Rula Btoush, PhD, RN Associate Professor Presented ented at the - - PowerPoint PPT Presentation

rula btoush phd rn associate professor
SMART_READER_LITE
LIVE PREVIEW

Rula Btoush, PhD, RN Associate Professor Presented ented at the - - PowerPoint PPT Presentation

Rula Btoush, PhD, RN Associate Professor Presented ented at the New ew Jersey sey HPV Roundta oundtable ble on n Octo tober ber 11, , 2017 017 Analysis of EHR data for 3,180 adolescents seen at a multi-site FQHC in Newark (2011)


slide-1
SLIDE 1

Rula Btoush, PhD, RN Associate Professor

Presented ented at the New ew Jersey sey HPV Roundta

  • undtable

ble on n Octo tober ber 11, , 2017 017

slide-2
SLIDE 2

 Analysis of EHR data for 3,180

adolescents seen at a multi-site FQHC in Newark (2011)

 Focus group discussions with 44

ethnically diverse Black women (2011)

 Focus group discussions with 132

Latina mothers (2014)

 Analysis of NJIIS data (2010-2014)

2

slide-3
SLIDE 3

An Anal alysis ysis of f EHR HR dat ata a fo for r 3,1 ,180 80 ad adolesce lescents nts seen n at at a mu a multi ti-site site FQHC QHC in Ne Newark wark (2011 011)

3

slide-4
SLIDE 4

 27.4% received at least 1 dose  HPV-V initiation was higher:

4

Facto tor ALL Female emale Male le Blac ack Hispan panic ic Younger adolescents     Non-English speakers    Insured adolescents   Seen by pediatricians      Seen at the Irvington

  • r Orange sites

     Younger adolescents seen by pediatricians     

slide-5
SLIDE 5

5

slide-6
SLIDE 6

 3-dose Series  7.8% of all adolescents  28.6% of adolescents who initiated  HPV-V Completion was higher:

6

Factor ctor ALL Female emale Male le Black ack Hispan panic ic Younger adolescents Non-English speakers   Insured adolescents  Seen by pediatricians Seen at the Newark – South or East Orange 

slide-7
SLIDE 7

 Duration between doses 1 and 2

  • 5.52

52 months (SD=4.63)

 Duration between doses 1 and 3

  • 10.02

.02 months (SD=6.07)

7

ALL Female emale Male le Black ack Hispan panic ic Insurance

  • Insurance
  • Insurance

ALL Female emale Male le Blac ack Hispan panic ic Insurance

  • Insurance
  • at Newark –

South or East Orange Non-English Speakers

  • at Newark –

South or East Orange

Should be 2 m months Should be 6 m months

slide-8
SLIDE 8

An Anal alysis ysis of f NJ NJIIS IS dat ata a (2010 010-2014 2014) Preliminary Analysis

8

slide-9
SLIDE 9

9

slide-10
SLIDE 10

10 10

slide-11
SLIDE 11

11 11

slide-12
SLIDE 12

12 12

slide-13
SLIDE 13

13 13

slide-14
SLIDE 14

Focus cus gr group up discussions cussions with th 44 ethnica hnically lly dive verse rse Blac ack k women men (2011 011)

Funded by the UMDNJ Foundation

14 14

slide-15
SLIDE 15

 Included Haitian, African, English-speaking

Caribbean, and African American women

 Lack of knowledge about:

  • HPV infection and risk factors
  • HPV vaccination guidelines

 Haitian & African mothers were least

knowledgeable

15 15

slide-16
SLIDE 16

 Distrust in vaccines in general  Open and receptive to vaccination for girls  Unclear about need to vaccinate boys  Concerns about safety and side effects  Lack of HCPs’ recommen

menda dation tion

  • In some cases HCPs were dismissive of women’s

questions (seeking information)

16 16

slide-17
SLIDE 17

Focus cus gr group up discussions cussions with th 132 2 La Latina na mo mothers thers (2014 014) Funded by the American Nurses Foundation (ANF)

17 17

slide-18
SLIDE 18

 Lower rates among:

  • Spanis

ish speakers ers (49%) than English speakers (90%)

  • Those with income
  • me

≤$14,000 (49%) than those with higher income (83%)

  • The uninsur

insured ed (47%) than the insured (64%)

18 18

slide-19
SLIDE 19

19 19

 Lower initiation

rates among:

  • Spanis

nish h speakers ers (24%) than English speakers (45%)

  • The uninsur

insured ed (16.2%) than the insured (39%)

  • Those who never

ver heard rd of the vacc ccine ine (3%) than those who ever heard of the vaccine (47%)

slide-20
SLIDE 20

 Lack of knowledge about HPV infection,

vaccination, recommended age of vaccination, number of doses, side effects, cost, etc.

 Receptive and believed that the vaccine

should be given to both males and females

 Mothers are the primary decision makers

about the vaccine

20 20

slide-21
SLIDE 21

Barr rrie iers: rs:

 Lack of HCP

recommen menda dation ion

 Concern about side

effects

 Avoidance of

talking about sex with children Faci cili litato ators: rs:

 HCP recommen

menda dation tion was the strong ngest est facil ilita itator

  • r for HPV-V

initiation and completion

 Perceived seriousness

  • f HPV (motivating

factor)

21 21

slide-22
SLIDE 22

 HCP

CP rec ecomm mmen endation ation an and co commun mmunica cati tion

  • n about

the HPV-V

  • Strong recommendation
  • Addressing side effects and safety concerns

 School-based approach in educating mothers

about the vaccine

 Use of texting smart phone technology to educate

mothers and promote completion

 Making appointments for 2nd and 3rd doses  Use of reminder calls for 2nd and 3rd doses

22 22

slide-23
SLIDE 23

Curre rrent t Pro roject ject - Stat atewide ewide On Online ine Survey rvey of f 500 0 HC HCPs Ps Funded by Rutgers Cancer Institute of New Jersey

23 23

slide-24
SLIDE 24

 St

Statewide ide onli line e survey ey of 500 HCPs

 Includes MDs & APNs in Peds, OB/GYN, and

family medicine

  • HCP recommendation of the HPV-V
  • Knowledge and beliefs about the vaccine
  • Barriers and facilitators for recommending and

discussing the HPV-V with parents

 Email announcements and word of mouth

24 24

slide-25
SLIDE 25

25 25

Sampl ple e charact aracteris eristic ics Ge Gender er Male Female 28% 78% Speci cialty alty Pediatrics Women’s Health or OB/GYN Family Medicine/Family Health 63% 15% 22% He Healthcare thcare Profes ession ion Physician Nurse Practitioner 78% 22% Pract ctic ice Type Private Practice Public Clinic FQHC Other 59% 16% 13% 12% Years s of Experience ience M ( (SD) D) 17 (11) Years s in current rrent pract ctice ice M ( (SD) D) 12 (11)

slide-26
SLIDE 26

26 26

* Recommending the HPV vaccine >75% of the time

slide-27
SLIDE 27

27 27

slide-28
SLIDE 28

28 28

slide-29
SLIDE 29

29 29

slide-30
SLIDE 30

30 30

slide-31
SLIDE 31

31 31

slide-32
SLIDE 32

32 32

slide-33
SLIDE 33

33 33

slide-34
SLIDE 34

 Healthcare providers in New Jersey  Physician (MD or DO) or advanced

practice nurse (APN or NP)

 Working in pediatrics, OB/GYN or

women’s health, or family medicine

 Online survey  < 20 minutes  http:/

://j.m j.mp/ p/2muD 2muDce8 e8

34 34

slide-35
SLIDE 35

35 35

slide-36
SLIDE 36

Ack cknowl nowledge edgeme ment nt of Collabo abora rators: tors:

 Diane Brown, PhD; Rutgers School of Public Health  Dennis Carmody, PhD; Rutgers School of Nursing  Shawna Hudson, PhD; Rutgers - Robert Wood Johnson Medical

School (RWJMS)

 Lindsey Toller, MPH; Rutgers School of Public Health  Jennifer Tsui, PhD, Rutgers Cancer Institute of New Jersey (CINJ)  DOH - VPD and VFC programs

36 36